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Background: The overexpression of histone deacetylase (HDAC) and a subsequent decrease in the acetylation
levels of nuclear histones are frequently observed in cancer cells. Generally it was accepted that the deacetylation
of histones suppressed expression of the attached genes. Therefore, it has been suggested that HDAC might
contribute to the survival of cancer cells by altering the NKG2D ligands transcripts. By the way, the translational
regulation of NKG2D ligands remaines unclear in cancer cells. It appears the modulation of this unclear mechanism
could enhance NKG2D ligand expressions and the susceptibility of cancer cells to NK cells. Previously, it was
reported that irradiation can increase the surface expressions of NKG2D ligands on several cancer cell types without
increasing the levels of NKG2D ligand transcripts via ataxia telangiectasia mutated and ataxia telangiectasia and
Rad3 related (ATM-ATR) pathway, and suggested that radiation therapy might be used to increase the translation of
NKG2D ligands.
Methods: Two NSCLC cell lines, that is, A549 and NCI-H23 cells, were used to investigate the combined effects of
ionizing radiation and HDAC inhibitors on the expressions of five NKG2D ligands. The mRNA expressions of the
NKG2D ligands were quantitated by multiplex reverse transcription-PCR. Surface protein expressions were measured
by flow cytometry, and the susceptibilities of cancer cells to NK cells were assayed by time-resolved fluorometry
using the DELFIA® EuTDA cytotoxicity kit and by flow cytometry.
Results: The expressions of NKG2D ligands were found to be regulated at the transcription and translation levels.
Ionizing radiation and HDAC inhibitors in combination synergistically increased the expressions of NKG2D ligands.
Furthermore, treatment with ATM-ATR inhibitors efficiently blocked the increased translations of NKG2D ligands
induced by ionizing radiation but did not block the increased ligand translations induced by HDAC inhibitors. The
study confirms that increased NKG2D ligand levels by ionizing radiation and HDAC inhibitors could synergistically
enhance the susceptibilities of cancer cells to NK-92 cells.
Conclusions: This study suggests that the expressions of NKG2D ligands are regulated in a complex manner at the
multilevel of gene expression, and that their expressions can be induced by combinatorial treatments in lung
cancer cells.
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It is well known NK cells play a role in immune surveil-
lance for cancer [1] and that their anticancer immunity
is controlled by a balance of activating and inhibitory
signals [2]. NKG2D is a well characterized immunore-
ceptor which mediates activating signals on NK cells and
T cell subsets, such as, CD8+ and γδT lymphocytes [3].
In humans, eight distinct NKG2D ligands, including
MHC class I chain-related gene A/B(MICA/B) and
UL16-binding protein 1–6 (ULBP1-6 or RAET1I,H,N,E,
G and L), have been described [4]. Furthermore, the
induction of NKG2D ligands by several methods, in-
cluding treatment with anti-cancer drugs, ionizing ra-
diation, heat shock, or proteasomal inhibition, has been
proposed as a strategy for eliciting anti-cancer immunity
[5-8]. Radiotherapy is a widely used modality to treat
cancer; it causes double-strand DNA breaks, and thus,
induces cancer cell death. Although it has been reported
that ionizing radiation can induce NKG2D ligands on
cancer cells by activating the ATM-ATR pathway [9],
the precise regulatory mechanism involved is unclear. Of
the recently developed anti-cancer agents, HDAC inhibi-
tors have been investigated in treatment of cancers, and
it has been reported that several HDAC inhibitors, in-
cluding suberoylanilide hydroxamic acid (SAHA), tricos-
tatin A (TSA), valproic acid, and PCI-24781, enhance
the radiosensitivities of cancer cells [10-13]. Because
HDAC inhibitors are known potent inducers of NKG2D
ligands on many cancer cells [14,15], it is possible that
the induced NKG2D ligands could overcome immune
tolerance and make cancer cells sensitive to NK-cell me-
diated cytotoxicity. Accordingly, we investigated whether
ionizing radiation in combination with HDAC inhibitor
treatment increases the expressions of NKG2D ligands,
and ATM-ATR signaling is involved in this process, and
this expressional increases enhances the susceptibility of
cancer cell to NK cells.
Materials and methods
Cell lines and reagents
Two human non-small cell lung cancer cell lines, A549 and
NCI-H23, were used in this study, and were obtained from
the Korean Cell Line Bank (Seoul, Korea). These cell lines
were maintained in RPMI media supplemented with 10%
fetal bovine serum (FBS) (Gibco, Grand Island, NY),
2 mM L-glutamine, 100 μg/ml streptomycin, and 100 U/ml
penicillin. The NK-92 cell line was obtained from the
American Type Culture Collection (Rockville, MD, USA)
and maintained in alpha-Minimum Essential Modified
medium supplemented with 12.5% (v/v) fetal bovine serum,
12.5% (v/v) horse serum, 2 mM L-glutamine,0.1 mM
2-mercaptoethanol, 200 U/mL of recombinant human
interleukin-2, 100 μg/mL streptomycin, and 100U/mL
penicillin. All cells were cultured at 37°C in a humidifiedatmosphere containing 5% CO2.Three HDAC inhibitors,
apicidin, suberoylanilide hydroxamic acid (SAHA; vorino-
stat) and tricostatin A (TSA), two ATM-ATR inhibitors,
caffeine, and KU-55933, cycloheximide (CHX) were pur-
chased from Sigma-Aldrich (St. Louis, MO, USA). To ir-
radiate cancer cells, we used a ClinaciX Linear Accelerator
(Varian Medical Systems, Inc. Palo Alto, CA, USA) with
the assistance of Dr. Jiho Nam (Pusan National University
Yangsan Hospital).
Total RNA extraction and Multiplex Reverse Transcription
(RT)-PCR
Total RNA extraction and RT-PCR were performed as
previously described [16]. Briefly, total RNA was extracted
from cells using the RNeasy® Mini Kit (Qiagen GmbH,
Germany). One microgram of extracted total RNA was
used to synthesize cDNA using 100 pmol of random
primers (Takara, Japan) and 100 U of M-MLV reverse
transcriptase (Promega Co., Fitchburg, Wisconsin, USA).
The resulting cDNA was used as template for PCR, which
was conducted using the QIAGEN® Multiplex PCR Kit
(Qiagen GmbH). Seven pairs of primer sets were used to
investigate the expressions of the ribosomal protein L19
(RPL19), MICA, MICB, ULBP1-3, and β-actin (ACTB)
genes. ACTB and RPL19 were used as a loading control
and a degradation marker, respectively. PCR products
were stained by ethidium bromide and separated by 2.0%
agarose gel electrophoresis, and quantified using image
analyzing software (Quantity One; Bio-Rad Laboratories,
Inc., Hercules, CA, USA).
Flow cytometry
To determine the surface expressions of NKG2D ligands
on cancer cells, the cells were incubated with mouse
anti-MICA, anti-MICB, anti-ULBP1-3 (R&D systems,
Minneapolis, MN, USA), anti-HLA-ABC (Clone W6/32,
Serotec, Oxford, UK) or the corresponding isotype con-
trols at 10 μg/ml and then incubated with goat anti-
mouse-PE conjugated (BD Pharmingen Inc., San Diego,
CA., USA). The analysis was performed on a FACS Sort®
(Becton Dickinson, Mountain View, CA., USA) using
Cell Quest software (Becton Dickinson), and cell surface
expressions were quantified using mean fluorescence
intensities (MFIs). Relative expression ratios were calcu-
lated by dividing treated sample MFI by untreated sam-
ple MFI without subtracting the MFI of the appropriate
isotype control.
NK cell-mediated cytotoxicity assay using time-resolved
fluorometry
NK cell-mediated cytotoxicity was determined using the
DELFIA® EuTDA Cytotoxicity Reagents (PerkinElmer Life
Sciences, Waltham, MA, USA), as described previously
[17]. Briefly, target cells (1X106 cells/ml) were incubated
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enhancing ligand) in 2 ml of culture medium for 30 min
at 37°C, and washed. Next, 100 μl of BATDA-labeled
target cells (5,000 cells) were transferred into a round-
bottom sterile plate and co-cultured with NK-92 cells for
2 hours at effector/target ratios ranging from 2.5:1 to 10:1.
After incubation, 20 μl of supernatant from each well was
transferred to the wells of flat-bottom 96 well plates.
180 μl of europium (Eu) solution was then added to form
highly fluorescent and stable chelates (EuTDA), and the
fluorescences of these chelates were measured by time-
resolved fluorometry (Victor3, PerkinElmer). The percent
of specific release was calculated using (experimental
release – spontaneous release)/(maximum release –
spontaneous release) X 100(%). In blocking experiments,
blocking anti-NKG2D mAb (R&D Systems) was pre-
added to suspensions of NK-92 cells and incubated for
30 min prior to co-cultured with target cells. All experi-
ments were performed in triplicate.
NK cell-mediated cytotoxicity assay by flow cytometry
Fresh NK cells were obtained from normal healthy donors
with informed consent in accordance with the Declaration
of Helsinki. Target cells (1X105 cells/ml) were stained
using the Vybrant® carboxyfluorescein diacetate, succini-
midyl ester (CFSE) Cell Tracer Kit (Invitrogen, Eugene,
OR, USA) and incubated with NK-92 cells or freshly iso-
lated NK cells at selected effector/target ratios for 2 hours
in 5 ml round-bottomed tubes. These co-cultured target
cells and NK cells were then stained with 1 μg/ml propi-
dium iodide (Sigma-Aldrich). The assay was performed on
FACS Sort® (Becton Dickinson) by acquiring 3,000 target
cells. The percent if specific release was calculated by the
number of PI+&CFSE+ cells/3,000 X 100 (%). All experi-
ments were performed in triplicate.
Statistical analysis
To evaluate alterations in gene expression, the gene ex-
pressions in treated cells were divided by those in un-
treated controls (mean fold) and standard errors (SE)
were calculated. To compare groups, we used the paired
Student’s t-test. Statistical significance was accepted for
p values < 0.05.
Results
HDAC inhibitors increase the mRNA expressions of
NKG2D ligands but ionizing radiation minimally alters
these expressions in A549 cells
The mRNA expressions of NKG2D ligands, MICA/B
and ULBP1-3, were analyzed after treating A549 cells
with three HDAC inhibitors, that is, 125 ng/ml apicidin,
2.5 μM SAHA, or 250 nM TSA, for 12 hours. Levels of
NKG2D ligands were significantly increased after treat-
ment with two HDAC inhibitors, apicidin and TSA, inA549 cells (Figure 1A). SAHA increased the mRNA
levels of only MICA and ULBP3. Although ULBP1 tend
to increase, alterations of ULBP1 transcript levels were
statistically insignificant in apicidin or SAHA treated
A549 cells. The mRNA levels of the five NKG2D ligands
were also significantly increased after treatment with the
three HDAC inhibitors in NCI-H23 cells (Figure 1B).
However, ionizing radiation did not significantly change
the mRNA levels of the five NKG2D ligands in A549
cells (Figure 1C). Although previous reports have shown
that ionizing radiation significantly increases the mRNA
and protein expressions of NKG2D ligands in several
cancer cells, including NCI-H23 cells [6], it was thought
that the induction of NKG2D ligands were different
from individual cancer cells. The reason for this lack of
responsive in A549 cells to ionizing radiation is not
clear.
Combination of HDAC inhibitors and ionizing radiation
prominently increases the surface expressions of NKG2D
ligands
Flow cytometric analysis showed that the cell surface
protein levels of the five NKG2D ligands were signifi-
cantly increased after treatment with 125 ng/ml apicidin
and 250 nM TSA for 18 hours following increased tran-
scripts in A549 cells. Although alterations in the protein
levels of MICA and ULBP2 were not significant, 8Gy of
irradiation and 24 hour-recovery incubation increased
the surface protein expressions of NKG2D ligands des-
pite little change in their mRNA levels. Relative ex-
pression ratios were calculated by dividing the MFI
ratios of treated samples by those of untreated samples.
These results suggested that the induction of NKG2D
ligands was achieved at different levels of gene expres-
sion by HDAC inhibitors and ionizing radiation differen-
tially. When HDAC inhibitors plus ionizing radiation
were administered to A549 cells, surface NKG2D ligand
protein levels were further increased as compared with
cells treated with HADC inhibitors or ionizing radiation
only (Figure 2A-B). We considered that this further in-
duction of NKG2D ligands might be due to the promo-
tion of transcription and post-transcription processes.
On the other hand, the surface expression of HLA-ABC,
which inhibits NK cells, was slightly increased after ion-
izing radiation but was blocked by HDAC inhibitor
(Figure 2C).
The susceptibility of A549 cells to NK cells is
synergistically increased by HDAC inhibitors treatment
and ionizing radiation in combination
To investigate whether treatment with HDAC inhibitor
and irradiation increase the NK cell-mediated lysis of
cancer cells, cytotoxicity assays were performed using
DELFIA® EuTDA Cytotoxicity Reagents. The susceptibility
AB
C
Figure 1 Analysis of the expressions of NKG2D ligands after treating lung cancer cells with HDAC inhibitors or ionizing radiation.
Multiplex RT-PCR analysis was performed to determine the mRNA expressions of NKG2D ligands. A549 and NCI-H23 cells were treated with
125 ng/ml apicidin, 2.5 μ M SAHA, or 250 nM TSA (A, B) for 12 hours. A549 cells were irradiated with the indicated doses and allowed to recover
for 24 hours (C). Amplified DNA was quantitated using Quantity-one software (Bio-rad). All experiments were performed at least three times, and
representative results are shown. MICA/B: MHC class I chain-related molecules A/B, ULBP1/2/3: UL16-binding proteins 1/2/3, ACTB: -actin, RPL19:
ribosomal protein19.
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creased by treatment with ionizing radiation plus TSA,
and this was prevented by adding blocking mAb
against NKG2D prior to the assay (Figure 3). Although
individual and experimental variations were high, cyto-
toxic assays using NK cells derived from three healthy
donors showed that the recognition of A549 cells by
freshly isolated NK cells tended to be further increased
by combination treatment (Additional file 1). These
results might indicate that the observed increase in NKcell-mediated lysis of A549 cells was due to the
increased expressions of NKG2D ligands. However,
despite significant induction of NKG2D ligands by
ionizing radiation, ionizing radiation did not signifi-
cantly increased the susceptibility of A549 cells to NK
cells. Although the reason is unclear, it is possible that
increased levels of inhibitory molecules (HLA-A/B/C)
in A549 cells might have affected their recognition to
NK cells. However this adverse effect of ionizing ra-
diation was prevented by HDAC inhibitors.















































































Figure 2 (See legend on next page.)
Son et al. Radiation Oncology 2014, 9:49 Page 5 of 10
http://www.ro-journal.com/content/9/1/49
(See figure on previous page.)
Figure 2 Cell surface expressions of NKG2D ligands after treating irradiated A549 cells with HDAC inhibitors. NKG2D ligand cell surface
expressions were analyzed by flow cytometry using specific mAbs against NKG2D ligands. A549 cells were irradiated with 8 Gy, allowed to
recover for 6 hours, and then treated with or without 250nM TSA or 125 ng/ml apicidin. The cells were then incubated for 18 hours. In the figure,
filled gray represents the isotype control and filled black represents the treated group (A). All experiments performed independently in triplicate
and significant differences between the untreated control and treated cells are presented as * (p < 0.05) or ** (p < 0.01). Ratios of mean
fluorescence intensities (MFI) obtained from treated cells and untreated control are shown (B). The further inductions of NKG2D ligands by
combination treatment as compared with treatment with HDAC inhibitors only are marked # (p < 0.05) or ## (p < 0.01). Changes in the surface
protein expressions of HLA-A/B/C were analyzed after ionizing radiation or TSA treatment (C).
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change the expressions of NKG2D ligands at the mRNA
level
It was demonstrated that ionizing radiation increases the
NKG2D ligands through ATM-ATR signaling [9,18]. To
investigate the role of ATM-ATR signaling, a selective
ATM-ATR inhibitor (KU-55933) and a broad nonspecific
inhibitor (caffeine) were used. Although mRNA of MICA
tended to decrease by treatment with caffeine, treatment
with KU-55933 or caffeine did not affect the expressions
of NKG2D ligands at the mRNA level (Figure 4A). Fur-
thermore, transcriptional alteration of NKG2D ligands
were not observed even after their combination with
ionizing radiation or HDAC inhibitors (Figure 4B, C).
ATM-ATR inhibitors block the inductions of surface
proteins of NKG2D ligands by ionizing radiation but not
their inductions by TSA
KU-55933 or caffeine did not affect the surface expres-
sions of NKG2D ligands, except MICA (Figure 5A). Caf-
feine essentially suppressed the expression of MICA at
surface protein level via an undefined mechanism. The
inductions of NKG2D ligands by ionizing radiation were




























Figure 3 Increased susceptibility of A549 cells to the cytolytic activity
co-treatment. A549 cells were not treated (open circle), irradiated with 8 Gy (
or co-treated with after ionizing radiation plus HDAC inhibitors (apicidin or TSA
effector/target ratio. To determine the specificity of NKG2D-mediated cytolysis,
(open triangle). All experiments were performed in triplicate and significant diff
were accepted for P values of < 0.05.(*; p < 0.05, **; p< 0.01).However, induction by TSA was not blocked by ATM-
ATR inhibitors, except that of MICA (Figure 5C). It was
suggested that the ATM-ATR pathway might have role in
the effects of ionizing radiation but be independent on the
expression of NKG2D ligands in inhibition of HDAC.
Protein synthesis inhibitor efficiently suppressed the
inductions of NKG2D ligands by TSA
Cycloheximide (CHX; a protein synthesis inhibitor) was
used to discriminate the level of NKG2D ligand regula-
tion. After CHX was administered, the mRNA and surface
protein levels of NKG2D ligands decreased regardless of
treatment type (Figure 6A, 6B left panel, Additional file 2).
Although the mechanism responsible for the suppressive
effect of CHX on the expressions of NKG2D ligands was
not determined, it was considered that the synthesis of
essential enzymes associated with gene transcription,
including RNA polymerases, might have been partially
inhibited by CHX. However, TSA did overcome the sup-
pressive effect of CHX on the transcriptions of NKG2D
ligands. The surface inductions of NKG2D ligands by TSA
was blocked by co-treatment with CHX (Figure 6B right
panel), which were not affected by co-treatment with




























of NK-92 cells following HDAC inhibitor and ionizing radiation
filled circle), treated with 125 ng/ml apicidin or 250 nM TSA (filled square),
; filled triangle). Cells were co-cultured with NK-92 cells at the indicated
NK-92 cells were pre-incubated with blocking mAb against NKG2D
erences between NK cell-mediated lyses of untreated and treated cells
*Caffeine : a widely used inhibitor capable of blocking both ATM and ATR catalytic activity













































Figure 4 Effects of ATM-ATR inhibitors on the transcriptions of NKG2D ligands in lung cancer cells. A549 cells were unaffected by KU-55933
or caffeine (A), though caffeine marginally suppressed MICA transcription. Radiation or radiation plus ATM-ATR inhibitors did not affect NKG2D ligand
transcription in A549 cells (B). The induced transcription of NKG2D ligands by HDAC inhibitors was not blocked by ATM-ATR inhibitors in A549 or
NCI-H23 cells (C).
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lation of NKG2D ligands through ATM-ATR signaling
might occur at prior step of protein synthesis via a me-
chanism independent of TSA.
Discussion
NK cells are remarkably cytotoxic to many different can-
cer cells in vitro and in vivo. Moreover, NK cell cytoto-
xicity is controlled by a signaling balance involving the
activations and inhibitions of cell surface receptors. Ac-
cordingly, the inductions of NKG2Dligands, which are
activating ligands in cancer cells, may provide an attrac-
tive means of promoting cancer cell recognition by NK
cells [19]. It is generally accepted that NKG2D surface
protein expressions are restricted in normal cells despite
of presence of their transcripts [20]. In our previousexperiments, the mRNA levels and surface protein ex-
pressions of NKG2D levels were often discordant. In
fact, some cancer cells exhibited increased NKG2D lig-
and surface expressions but no change in mRNA levels
after irradiation, which suggests the expressions of
NKG2D ligands are strictly regulated at transcriptional
and post-transcriptional levels.
A variety of stresses, such as, heat shock and exposure
to hydrogen peroxide, DNA damaging agents, or viral or
bacterial infection can increase the expressions of MICA/
B [8,9,21,22], although the mechanisms involved remain
unclear. Recently, it was reported that chromatin remodel-
ing agents, such as, inhibitors of DNA methyltransferase
or nuclear histone deacetylase increase the expressions of
many proapoptotic or tumor suppressor genes, and thus
can induce the growth arrest, differentiation, and apoptosis
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Figure 5 Effects of ATM-ATR inhibitors on the surface expressions of NKG2D ligands in A549 cells. The surface protein expressions of
NKG2D ligands on A549 cells, MICA, were unaffected by KU-55933 or caffeine (A); caffeine significantly decreased the surface expression of MICA. The
induction of NKG2D ligands surface protein by ionizing radiation was blocked by ATM-ATR inhibitors in A549 cells, although difference of ULBP2 was
not significant. (B). The induction of the surface expressions of NKG2D ligands by HDAC inhibitors was not blocked by ATM-ATR inhibitors in A549 cells,



























Figure 6 Induction of surface NKG2D ligands by TSA treatment was blocked by CHX in A549 cells. A549 cells were treated with CHX
(1 μg/ml) and 250 nM TSA for 18 hours, and single treatment of CHX reduced the transcription of NKG2D ligands (A). However, the transcriptional
induction of NKG2D ligands by TSA was not blocked by co-treatment with CHX (B). Although the suppressions of ULBP1-3 were not statistically
significant, CHX effectively blocked the surface expression of MICA and MICB by TSA. Filled gray, filled dark gray, thick line and thin line represent
isotype control, untreated control, CHX or TSA single treatments, and TSA plus CHX combined treatment, respectively. Significant differences between
untreated control and treated cells are presented as * (p < 0.05) or ** (p < 0.01).
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NKG2D ligands have been reported to be upregulated at
the transcription level in some cancer cells [14,15,26]. On
the other hand, DNA damaging agents usually increase
the surface expressions of NKG2D ligands at post-tran-
scriptional level in macrophage through ATM-ATR sig-
naling [18]. Therefore, to further increase the expression
of NKG2D ligands in cancer cells, we co-treated cells with
ionizing radiation and HDAC inhibitors. We presumed
that HDAC inhibitors increase the transcription and ioni-
zing radiation increases the translation of NKG2D ligands
via different mechanisms.
The lung adenocarcinoma cell line A549 is resistant to
ionizing radiation and to cell-mediated killing [27,28]. In
the present study, we found that ionizing radiation did not
significantly increase NKG2D ligand transcript expression
in this cell line, but it did increase their protein levels. On
the other hand, ionizing radiation significantly increased
the expressions of NKG2D ligands at the mRNA and pro-
tein levels in NCI-H23 cells (a radiosensitive lung adeno-
carcinoma cell line). Although we did not investigate the
reason for the different responses to ionizing radiation of
these two lung cancer cells, it has been shown that they
exhibit different p53 activities [29]. Accordingly, our fin-
dings suggest that ionizing radiation and HDAC inhibitor
co-treatment increase NKG2D ligand expression and en-
hance the susceptibility of cancer cells to NK-92 cells and
freshly isolated NK cells (Figure 3 and Additional file 1).
To examine the effects of ionizing radiation and of
HDAC inhibitor treatment separately, we inhibited
ATM-ATR signaling, which is activated by ionizing ra-
diation and increased the NKG2D ligand expression [9].
We choose two ATM-ATR inhibitors, that is, caffeine
and KU-55933, and pretreated cancer cells with these
inhibitors prior to administering ionizing radiation or
HDAC inhibitors. ATM-ATR inhibitors effectively
blocked the induction of NKG2D ligands by ionizing
radiation. However, not by HDAC inhibitors except
MICA. These findings show that ionizing radiation and
HDAC inhibitors differentially affect the ATM-ATR
pathway and NKG2D ligand expression. More speci-
fically, caffeine suppressed the expression of MICA at
the surface protein level (Figure 5), and although the
mechanism of MICA down-regulation by caffeine is not
known, it has been reported that MICA transcription is
reduced via the inhibitions of PI3K and PKC, which re-
gulators of MICA transcription [17,30] and caffeine
might affect the PI3K and PKC activities. CHX (an
inhibitor of protein synthesis) treatment effectively
blocked NKG2D ligand induction by HDAC inhibitors.
We are of the opinion that ATM-ATR signaling pro-
bably does not increase the protein synthesis of NKG2D
ligands but rather promotes their translation at a prior
step of protein synthesis.In previous studies, post-transcriptional and -translational
regulations were found to be involved in the control of the
surface protein levels of NKG2D ligands, and discre-
pancies between the transcription and surface NKG2D ex-
pressions of ligands have often been described [31-33].
We found that co-treatment with ionizing radiation and
HDAC inhibitors further increases NKG2D ligand expres-
sions via independent mechanisms in lung cancer cells.
BecauseA549 cells did not response to ionizing radiation
with respect to the transcriptions of NKG2D ligands and
these cells were essentially less susceptible to NK cells, it
would appear in this cell-line that by ionizing radiation in
the inductions of the surface protein expressions of
NKG2D ligands were limited. Although radioresistant
lung cancer cells, such as, A549 cells, survive even high-
doses irradiation, it appears that co-treatment with ioni-
zing radiation and HDAC inhibitors might be helpful.
Conclusions
This study suggests NKG2D ligands are regulated in a
complex, multi-level manner and that they can be induced
by ionizing radiation plus HDAC inhibitors in lung cancer
cells. We believe that such combination therapies offer an
attractive means of improving the efficacy of NK cell-
based cancer immunotherapy in patients with radioresis-
tant cancer.
Additional files
Additional file 1: Increased susceptibility of A549 cells to the
cytolytic activities of fresh isolated NK cells after treatment with
ionizing radiation plus TSA. A549 cells were co-cultured with NK-92
cells or freshly isolated NK cells, the latter of which were obtained from
three healthy donors after obtaining informed consent, at the indicated
effector/target ratio. The cytotoxicity assay was performed by using flow
cytometry and representative results were shown (A). Cytotoxicity assay
results were shown as marks (B). untreated (open circle), or irradiated
with 8 Gy (filled circle), with 250 nM TSA (filled square), or with RT plus
TSA (filled triangle). All experiments were performed in triplicate and
significant differences between NK cell-mediated lyses of untreated and
treated cells were accepted for P values of <0.05.(* ;P < 0.05).
Additional file 2: Blockade of the radiation-induced surface expressions
of NKG2D ligands by CHX in A549 cells. A549 cells were irradiated with
8 Gy, allowed to recover for 6 hours, and then treated with or without
250nM TSA or 125 ng/ml apicidin. Cells were then incubated for
18 hours. Filled gray represents the isotype control, filled dark gray the
untreated control, the thick line represents irradiated cells, and the thin
line represents ionizing radiation plus CHX treated cells.
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